CMS urged to change GLP-1 drug coverage determination
Fierce Healthcare
SEPTEMBER 25, 2023
Healthcare organizations are continuing to push the Centers for Medicare & Medicaid Services (CMS) to rethink its coverage policy for anti-obesity medications. | Critics say that the view CMS has of certain anti-obesity medications is outdated and could be covered under Medicare Part D.
Let's personalize your content